EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • July 31st, 2020 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 31st, 2020 Company Industry JurisdictionTHIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is made as of June 18, 2019, by and among Ultragenyx Pharmaceutical Inc., a Delaware corporation (the “Investor”), Arcturus Therapeutics Ltd., an Israeli incorporated company (“Arcturus-Israel”), and Arcturus Therapeutics Holdings Inc., a newly incorporated Delaware corporation (“Arcturus-Delaware”).
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • June 20th, 2019 • Arcturus Therapeutics Ltd. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 20th, 2019 Company Industry JurisdictionTHIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is made as of June 18, 2019, by and among Ultragenyx Pharmaceutical Inc., a Delaware corporation (the “Investor”), Arcturus Therapeutics Ltd., an Israeli incorporated company (“Arcturus-Israel”), and Arcturus Therapeutics Holdings Inc., a newly incorporated Delaware corporation (“Arcturus-Delaware”).